Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Evguenia Gachimova, MD
CONTACT
Lead
M.D. Anderson Cancer Center
With
Primary Objectives: * To determine the safety and tolerability of ivonescimab in adult patients with recurrent glioblastoma * To determine the median progression free survival and progression free survival rate at 6 months of ivonescimab in adult patients with recurrent glioblastoma
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
